Alternatives to Network Bio

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

A vertically-integrated procurement platform for the life sciences industry.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

Automated wet lab for AI-driven protein design, enabling rapid synthesis, expression, and testing of thousands of protein designs.

Earendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.

A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.

Engineering scalable gene therapies for broader patient populations.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

Biotechnology company developing next-generation gene therapies using a proprietary protein splicing platform.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

Developing oral small molecule medicines for immunological and chronic diseases.

An end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials, focusing on lung and heart disease.

AI-native biotech company designing next-generation CAR T therapies for solid tumors.